BLCM insider filings
BELLICUM PHARMACEUTICALS, INC — 46 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-11-24. Screen BLCM transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BLCM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — BELLICUM PHARMACEUTICALS, INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-11-24 | 4 | BAKER BROS. ADVISORS LP — 10% owner BAKER JULIAN — 10% owner BAKER FELIX — 10% owner Baker Bros. Advisors (GP) LLC — 10% owner | Option exercise/expiry (X): 174,742 @ $0.00 · Option exercise/expiry (X): 1,941,607 @ $0.00 · Option exercise/expiry (X): 174,742 (derivative) @ $0 · Option exercise/expiry (X): 1,941,607 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4/A | Huber Reid M — Director | Option exercise (M): 80,968 @ $0 | EDGAR |
| 2023-01-05 | 4 | Daly James M — Director | Option exercise (M): 60,414 @ $0 | EDGAR |
| 2023-01-05 | 4 | Huber Reid M — Director | Option exercise (M): 87,196 @ $0 | EDGAR |
| 2023-01-05 | 4 | Stonehouse Jon P — Director | Option exercise (M): 121,452 @ $0 | EDGAR |
| 2023-01-05 | 4 | Klimovsky Judith V — Director | Option exercise (M): 60,414 @ $0 | EDGAR |
| 2023-01-05 | 4 | DAVIS STEPHEN — Director | Option exercise (M): 74,739 @ $0 | EDGAR |
| 2023-01-04 | 4/A | Stonehouse Jon P — Director | Option exercise (M): 60,580 @ $0 | EDGAR |
| 2022-09-02 | 4 | Klimovsky Judith V — Director | Option exercise (M): 35,082 @ $0 | EDGAR |
| 2022-09-02 | 4 | Daly James M — Director | Option exercise (M): 35,082 @ $0 | EDGAR |
| 2022-09-02 | 4 | Huber Reid M — Director | Option exercise (M): 46,489 @ $0 | EDGAR |
| 2022-09-02 | 4 | Stonehouse Jon P — Director | Option exercise (M): 60,580 @ $0 | EDGAR |
| 2022-09-02 | 4 | DAVIS STEPHEN — Director | Option exercise (M): 43,400 @ $0 | EDGAR |
| 2022-09-01 | 4/A | Stonehouse Jon P — Director | Option exercise (M): 21,054 @ $0 · Option exercise (M): 21,054 (derivative) @ $0 | EDGAR |
| 2022-08-16 | 4 | Scripture Charity — Chief Development Officer | Grant/award (A): 250,000 (derivative) @ $1.44 | EDGAR |
| 2022-08-16 | 4 | Fair Richard A. — President and CEO, Director | Grant/award (A): 400,000 (derivative) @ $1.44 | EDGAR |
| 2022-06-16 | 4 | Stonehouse Jon P — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Klimovsky Judith V — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Daly James M — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Huber Reid M — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | DAVIS STEPHEN — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Huber Reid M — Director | Option exercise (M): 19,494 @ $0 · Option exercise (M): 19,494 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | BROWN JAMES F — Director | Option exercise (M): 28,384 @ $0 · Option exercise (M): 28,384 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Stonehouse Jon P — Director | Option exercise (M): 21,504 @ $0 · Option exercise (M): 21,504 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Daly James M — Director | Option exercise (M): 13,568 @ $0 · Option exercise (M): 809 @ $0 · Option exercise (M): 13,568 (derivative) @ $0 · Option exercise (M): 809 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Klimovsky Judith V — Director | Option exercise (M): 14,036 @ $0 · Option exercise (M): 566 @ $0 · Option exercise (M): 14,036 (derivative) @ $0 · Option exercise (M): 566 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | DAVIS STEPHEN — Director | Option exercise (M): 18,715 @ $0 · Option exercise (M): 18,715 (derivative) @ $0 | EDGAR |
| 2021-12-02 | 4 | Scripture Charity — Chief Development Officer | Grant/award (A): 150,000 (derivative) @ $1.73 | EDGAR |
| 2021-08-18 | 4/A | Fair Richard A. — President and CEO, Director | Grant/award (A): 265,000 (derivative) @ $0 | EDGAR |
| 2021-08-16 | 4 | Fair Richard A. — President and CEO, Director | Grant/award (A): 265,000 (derivative) @ $0 | EDGAR |
| 2021-07-07 | 4 | Stonehouse Jon P — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2021-07-07 | 4 | Klimovsky Judith V — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2021-07-07 | 4 | Huber Reid M — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2021-07-07 | 4 | Daly James M — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2021-07-07 | 4 | BROWN JAMES F — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2021-07-07 | 4 | DAVIS STEPHEN — Director | Grant/award (A): 6,500 (derivative) @ $0 | EDGAR |
| 2021-07-06 | 4 | Klimovsky Judith V — Director | Grant/award (A): 566 (derivative) @ $0 | EDGAR |
| 2021-07-06 | 4 | Daly James M — Director | Grant/award (A): 809 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | Stonehouse Jon P — Director | Grant/award (A): 21,054 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | Klimovsky Judith V — Director | Grant/award (A): 14,036 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | Huber Reid M — Director | Grant/award (A): 19,494 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | BROWN JAMES F — Director | Grant/award (A): 28,384 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | Daly James M — Director | Grant/award (A): 13,568 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | DAVIS STEPHEN — Director | Grant/award (A): 18,715 (derivative) @ $0 | EDGAR |
| 2020-12-16 | 4 | Strauss David Eric — Sr Director, Corp Controller | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2020-12-16 | 4 | Fair Richard A. — President and CEO, Director | Grant/award (A): 286,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — BELLICUM PHARMACEUTICALS, INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-02-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-21 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-24 | 8-K | 3.02 — Unregistered Sales of Equity Securities 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-12-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-21 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2023-06-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-05-30 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BLCM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs